Journal of Nihon University Medical Association
Online ISSN : 1884-0779
Print ISSN : 0029-0424
ISSN-L : 0029-0424
Casel Reports:
Complete Response of Multiple Pulmonary Metastases from Colon Cancer to SOX + Cetuximab and FOLFIRI + Cetuximab after Resection of the Primary Lesion and Hepatic Metastasis
Shunta YakuboMitsugu KochiTadatoshi Takayama
Author information
JOURNAL FREE ACCESS

2014 Volume 73 Issue 5 Pages 227-229

Details
Abstract
The patient was a 64-year-old woman who was referred to our hospital in February 2010 with the diagnosis of liver metastases from the ascending colon cancer after resection of the primary lesion. After two hepatectomies were performed, a computed tomography scan revealed multiple metastatic lesions in the chest in October 2012. Chemotherapy comprising SOX plus Cetuximab and FOLFIRI plus Cetuximab for pulmonary metastases of ascending colon cancer was commenced. A subsequent computed tomography scan in February 2013 revealed that the multiple pulmonary metastatic lesions had disappeared. A complete response of the pulmonary metastases of ascending colon cancer to SOX plus Cetuximab and FOLFIRI plus Cetuximab in was observed. The patient was still alive with no signs of recurrence 19 months after the start of chemotherapy. Conclusion: These results suggest that complete remission from colon cancer with pulmonary metastases can be obtained with chemotherapy alone when SOX or FOLFIRI plus Cetuximab are included in the regimen.
Content from these authors
© 2014 The Nihon University Medical Association
Previous article Next article
feedback
Top